SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-21-017125
Filing Date
2021-05-13
Accepted
2021-05-13 08:07:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 brhc10024518_425.htm 425 37322
2 EXHIBIT 99.1 brhc10024518_ex99-1.htm EX-99.1 13324
3 image00001.jpg GRAPHIC 2549
  Complete submission text file 0001140361-21-017125.txt   55978
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filed by) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-27756 | Film No.: 21917289
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences